Adverse drug events: Database construction and in silico prediction

Journal of Chemical Information and Modeling

Volumn 53, Issue 4, 2013, Pages 744-752

  Cheng, Feixiong ^a   Li, Weihua ^a   Wang, Xichuan ^b   Zhou, Yadi ^a   Wu, Zengrui ^a   Shen, Jie ^a   Tang, Yun ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CENTRAL RESEARCH INSTITUTE OF BUILDING AND CONSTRUCTION CO   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DATA INTEGRATION; DATABASE SYSTEMS; DRUG INTERACTIONS; FORECASTING; TEXT MINING;

10-FOLD CROSS-VALIDATION; ADVERSE EVENTS; DATABASE CONSTRUCTION; MEDICAL SUBJECT HEADINGS; NETWORK INFERENCE; PREDICTION CAPABILITY; RECEIVE OPERATING CHARACTERISTICS; REPORTING SYSTEMS;

DRUG DOSAGE;

PRESCRIPTION DRUG;

ALGORITHM; AREA UNDER THE CURVE; ARTICLE; COMPUTER SIMULATION; DATA MINING; DRUG DATABASE; FACTUAL DATABASE; HUMAN; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL;

ALGORITHMS; AREA UNDER CURVE; COMPUTER SIMULATION; DATA MINING; DATABASES, FACTUAL; DATABASES, PHARMACEUTICAL; HUMANS; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PRESCRIPTION DRUGS; ROC CURVE;

EID: 84876575669     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci4000079     Document Type: Article

References (40)

1. Lazarou, J.; Pomeranz, B. H.; Corey, P. N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies JAMA, J. Am. Med. Assoc. 1998, 279, 1200-1205
2. Tatonetti, N. P.; Ye, P. P.; Daneshjou, R.; Altman, R. B. Data-driven prediction of drug effects and interactions Sci. Transl. Med. 2012, 4, 125ra131
3. Kuhn, M.; Campillos, M.; Letunic, I.; Jensen, L. J.; Bork, P. A side effect resource to capture phenotypic effects of drugs Mol. Syst. Biol. 2010, 6, 343
4. Davis, A. P.; King, B. L.; Mockus, S.; Murphy, C. G.; Saraceni-Richards, C.; Rosenstein, M.; Wiegers, T.; Mattingly, C. J. The Comparative Toxicogenomics Database: update 2011 Nucleic Acids Res. 2011, 39, D1067-1072
5. Jensen, L. J.; Saric, J.; Bork, P. Literature mining for the biologist: from information retrieval to biological discovery Nat. Rev. Genet. 2006, 7, 119-129
6. Amberger, J.; Bocchini, C. A.; Scott, A. F.; Hamosh, A. McKusick's Online Mendelian Inheritance in Man (OMIM) Nucleic Acids Res. 2009, 37, D793-796
7. Ingelman-Sundberg, M. Pharmacogenomic biomarkers for prediction of severe adverse drug reactions N. Engl. J. Med. 2008, 358, 637-639
8. Harpaz, R.; Dumouchel, W.; Shah, N. H.; Madigan, D.; Ryan, P.; Friedman, C. Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis Clin. Pharmacol. Ther. 2012, 91, 1010-1021
9. Pouliot, Y.; Chiang, A. P.; Butte, A. J. Predicting adverse drug reactions using publicly available PubChem BioAssay data Clin. Pharmacol. Ther. 2011, 90, 90-99
10. Ball, R.; Botsis, T. Can network analysis improve pattern recognition among adverse events following immunization reported to VAERS? Clin. Pharmacol. Ther. 2011, 90, 271-278
11. Huang, L. C.; Wu, X.; Chen, J. Y. Predicting adverse side effects of drugs BMC Genom. 2011, 12 (Suppl 5) S11
12. Harpaz, R.; Perez, H.; Chase, H. S.; Rabadan, R.; Hripcsak, G.; Friedman, C. Biclustering of adverse drug events in the FDA's spontaneous reporting system Clin. Pharmacol. Ther. 2010, 89, 243-250
13. Tatonetti, N. P.; Liu, T.; Altman, R. B. Predicting drug side-effects by chemical systems biology Genome Biol. 2009, 10, 238
14. Harpaz, R.; Perez, H.; Chase, H. S.; Rabadan, R.; Hripcsak, G.; Friedman, C. Biclustering of adverse drug events in the FDA's spontaneous reporting system Clin. Pharmacol. Ther. 2011, 89, 243-250
15. Adkins, D. E.; Aberg, K.; McClay, J. L.; Bukszar, J.; Zhao, Z.; Jia, P.; Stroup, T. S.; Perkins, D.; McEvoy, J. P.; Lieberman, J. A.; Sullivan, P. F.; van den Oord, E. J. Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs Mol. Psychiat. 2011, 16, 321-332
16. Chiang, A. P.; Butte, A. J. Data-driven methods to discover molecular determinants of serious adverse drug events Clin. Pharmacol. Ther. 2009, 85, 259-268
17. Liu, M.; Wu, Y.; Chen, Y.; Sun, J.; Zhao, Z.; Chen, X. W.; Matheny, M. E.; Xu, H. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs J. Am. Med. Inf. Assoc. 2012, 19, e28-e35
18. Abernethy, D. R.; Woodcock, J.; Lesko, L. J. Pharmacological mechanism-based drug safety assessment and prediction Clin. Pharmacol. Ther. 2011, 89, 793-797
19. Yang, L.; Wang, K.; Chen, J.; Jegga, A. G.; Luo, H.; Shi, L.; Wan, C.; Guo, X.; Qin, S.; He, G.; Feng, G.; He, L. Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome -clozapine-induced agranulocytosis as a case study PLoS Comput. Biol. 2011, 7, e1002016
20. Xie, L.; Wang, J.; Bourne, P. E. In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators PLoS Comput. Biol. 2007, 3, e217 10.1371/journal.pcbi.0030217
21. Xie, L.; Li, J.; Bourne, P. E. Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors PLoS Comput. Biol. 2009, 5, e1000387
22. Cami, A.; Arnold, A.; Manzi, S.; Reis, B. Predicting adverse drug events using pharmacological network models Sci. Transl. Med. 2011, 3, 114ra127
23. Yamanishi, Y.; Pauwels, E.; Saigo, H.; Stoven, V. Extracting Sets of Chemical Substructures and Protein Domains Governing Drug-Target Interactions J. Chem. Inf. Model. 2012, 52, 3284-3292
24. Tatonetti, N. P.; Fernald, G. H.; Altman, R. B. A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports J. Am. Med. Inf. Assoc. 2012, 19, 79-85
25. Bate, A.; Evans, S. J. Quantitative signal detection using spontaneous ADR reporting Pharmacoepidem. Dr. S. 2009, 18, 427-436
26. Szarfman, A.; Machado, S. G.; O'Neill, R. T. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database Drug Safety 2002, 25, 381-392
27. Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs Nucleic Acids Res. 2011, 39, D1035-1041
28. Zhu, F.; Shi, Z.; Qin, C.; Tao, L.; Liu, X.; Xu, F.; Zhang, L.; Song, Y.; Zhang, J.; Han, B.; Zhang, P.; Chen, Y. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery Nucleic Acids Res. 2012, 40, D1128-1136
29. Hernandez-Boussard, T.; Whirl-Carrillo, M.; Hebert, J. M.; Gong, L.; Owen, R.; Gong, M.; Gor, W.; Liu, F.; Truong, C.; Whaley, R.; Woon, M.; Zhou, T.; Altman, R. B.; Klein, T. E. The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge Nucleic Acids Res. 2008, 36, D913-918
30. Boyle, N. M; Banck, M.; James, C. A.; Morley, C.; Vandermeersch, T.; Hutchison, G. R. Open Babel: an open chemical toolbox. J. Cheminf. [Online] 2011, 3, Article 33; http://www.jcheminf.com/content/3/1/33 (accessed Nov 19, 2011).
31. Cheng, F.; Li, W.; Zhou, Y.; Shen, J.; Wu, Z.; Liu, G.; Lee, P. W.; Tang, Y. admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties J. Chem. Inf. Model. 2012, 52, 3099-3105
32. Seebacher, J.; Gavin, A. C. SnapShot: Protein-protein interaction networks Cell 2011, 144, 1000-1000.e1
33. Matthieu, L.; Mahnien, C.; Vecchio, N. D. Basic notions for the analysis of large two-mode networks Social Networks 2008, 30, 31-48
34. Cheng, F.; Liu, C.; Jiang, J.; Lu, W.; Li, W.; Liu, G.; Zhou, W.; Huang, J.; Tang, Y. Prediction of drug-target interactions and drug repositioning via network-based inference PLoS Comput. Biol. 2012, 8, e1002503
35. Cheng, F.; Zhou, Y.; Li, W.; Liu, G.; Tang, Y. Prediction of chemical-protein interactions network with weighted network-based inference method PLoS One 2012, 7, e41064
36. Takarabe, M.; Kotera, M.; Nishimura, Y.; Goto, S.; Yamanishi, Y. Drug target prediction using adverse event report systems: a pharmacogenomic approach Bioinformatics 2012, 28, i611-i618
37. Bodenreider, O. The Unified Medical Language System (UMLS): integrating biomedical terminology Nucleic Acids Res. 2004, 32, D267-270
38. Davis, J.; Goadrich, M. The Relationship Between Precision-Recall and ROC Curves. In Proceedings of the Twenty Third International Conference on Machine Learning; Pittsburgh, PA, June 25-29, 2006; Cohen, W. W. A. M., Ed.; ACM Press: PA, 2006; pp 233-240.
39. Rosenzweig, P.; Brohier, S.; Zipfel, A. The placebo effect in healthy volunteers: influence of experimental conditions on the adverse events profile during phase I studies Clin. Pharmacol. Ther. 1993, 54, 578-583
40. Harrison, C. GlaxoSmithKline opens the door on clinical data sharing Nat. Rev. Drug Discovery 2012, 11, 891-892